Patents by Inventor Anne Brochard

Anne Brochard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release formulations comprising GNRH analogues
    Patent number: 8962559
    Abstract: The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogs thereof and the manufacturing process of such pharmaceutical compositions.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: February 24, 2015
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Roland Cherif-Cheikh, Fédéric Lacombe, Maria-Luisa Torres Salgado, Perrine Cambriel, Mercé Cardus Malaspina, Isabel Diaz Del Consuelo, Martin Montes, Fabien Jeannerot, Marie Delporte, Anne Brochard, Joël Richard
  • SUSTAINED RELEASE FORMULATIONS COMPRISING GNRH ANALOGUES
    Publication number: 20150004210
    Abstract: The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogues thereof and the manufacturing process of such pharmaceutical compositions.
    Type: Application
    Filed: September 18, 2014
    Publication date: January 1, 2015
    Inventors: Roland CHERIF-CHEIKH, Fédéric LACOMBE, Maria-Luisa TORRES SALGADO, Perrine CAMBRIEL, Mercè CARDUS MALASPINA, Isabel DIAZ DEL CONSUELO, Martin MONTES, Fabien JEANNEROT, Marie DELPORTE, Anne BROCHARD, Joël RICHARD
  • SOLID PHARMACEUTICAL COMPOSITION CONTAINING 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA (C)CHROMEN-3-YL SULFAMATE AND POLYMORPHS THEREOF
    Publication number: 20140056977
    Abstract: The present invention relates to a solid pharmaceutical composition including the active principle 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. The present invention also relates to polymorphs of the 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate compound.
    Type: Application
    Filed: August 1, 2013
    Publication date: February 27, 2014
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Nathalie MONDOLY, Bertrand Poirot, Anne Brochard, Joël Richard, Delphine Delahaye, Christian Diolez, Alain Rolland, Francis Diancourt, Gérard Coquerel, Damien Martins, Julie Linol, Ophélie Houssin, Marie-Noêlle Petit, Barry, Victor, Lloyd Potter, Lok, Wai Lawrence Woo
  • SOLID PHARMACEUTICAL COMPOSITION CONTAINING 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA (C)CHROMEN-3-YL SULFAMATE AND POLYMORPHS THEREOF
    Publication number: 20120321714
    Abstract: The present invention relates to a solid pharmaceutical composition including the active principle 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. The present invention also relates to polymorphs of the 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate compound.
    Type: Application
    Filed: March 26, 2012
    Publication date: December 20, 2012
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Nathalie MONDOLY, Bertrand Poirot, Anne Brochard, Joël Richard, Delphine Delahaye, Christian Diolez, Alain Rolland, Francis Diancourt, Gérard Coquerel, Damien Martins, Julie Linol, Marie-Noêlle Petit, Barry Victor Llyod Potter, Lok, Wai Lawrence Woo
  • SUSTAINED RELEASE FORMULATIONS COMPRISING GnRH ANALOGUES
    Publication number: 20120202743
    Abstract: The present invention relates to pharmaceutical compositions for the controlled and sustained release of active substance comprising a biodegradable polymer or copolymer. Furthermore, the invention relates to pharmaceutical compositions for the controlled and sustained release of at least one active substance such as peptides or hormones and analogues thereof and the manufacturing process of such pharmaceutical compositions.
    Type: Application
    Filed: April 29, 2010
    Publication date: August 9, 2012
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Roland Cherif-Cheikh, Fédéric Lacombe, Maria-Luisa Torres Salgado, Perrine Cambriel, Mercé Cardus Malaspina, Isabel Diaz Del Consuelo, Martin Montes, Fabien Jeannerot, Marie Delporte, Anne Brochard, Joël Richard
  • GLP-1 ANALOGUES PHARMACEUTICAL COMPOSITIONS
    Publication number: 20120077746
    Abstract: The present invention is directed to sustained release liquid pharmaceutical compositions comprising a liquid, a peptide analogue according to the formula [Aib8,35]hGLP-1 (7-36)NH2, a divalent metal and/or divalent metal salt, and an acetate salt and/or acetic acid. The invention also relates to containers comprising the pharmaceutical compositions and methods for preparing the pharmaceutical compositions.
    Type: Application
    Filed: February 8, 2010
    Publication date: March 29, 2012
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Nathalie Mondoly, Anne Brochard